INTERPRETIVE CRITERIA FOR THE AGAR DIFFUSION SUSCEPTIBILITY TEST WITH ENOXACIN

被引:3
作者
GRIMM, H
机构
关键词
D O I
10.1093/jac/14.suppl_C.39
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:39 / 45
页数:7
相关论文
共 8 条
[1]  
BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
[2]  
CHIN N, 1983, 23RD INT C ANT AG CH
[3]   INVITRO ACTIVITY OF ENOXACIN, A QUINOLONE CARBOXYLIC-ACID, COMPARED WITH THOSE OF NORFLOXACIN, NEW BETA-LACTAMS, AMINOGLYCOSIDES, AND TRIMETHOPRIM [J].
CHIN, NX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :754-763
[4]  
Ericsson H. M., 1971, ACTA PATHOL MICROB S, V217, P1
[5]  
GRIMM H, 1983, 23RD INT C ANT AG CH
[6]   INVITRO ANTI-BACTERIAL PROPERTIES OF AT-2266, A NEW PYRIDONECARBOXYLIC ACID [J].
NAKAMURA, S ;
MINAMI, A ;
KATAE, H ;
INOUE, S ;
YAMAGISHI, J ;
TAKASE, Y ;
SHIMIZU, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) :641-648
[7]   INVITRO AND INVIVO ACTIVITY OF DL-8280, A NEW OXAZINE DERIVATIVE [J].
SATO, K ;
MATSUURA, Y ;
INOUE, M ;
UNE, T ;
OSADA, Y ;
OGAWA, H ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (04) :548-553
[8]   TENTATIVE INTERPRETIVE STANDARDS FOR DISK DIFFUSION SUSCEPTIBILITY TESTING WITH NORFLOXACIN (MK-0366, AM-715) [J].
SHUNGU, DL ;
WEINBERG, E ;
GADEBUSCH, HH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (02) :256-260